Pr-liver, lesion(s) after Polysulfated Glycosaminoglycan in dogs

The FDA has received 22 reports of pr-liver, lesion(s) in dogs after Polysulfated Glycosaminoglycan. That is 0.4% of all reports for this medicine, compared with 0.3% across reports for all dog medicines, so it is reported unusually often with this medicine.

22Reports

45%Marked serious

0.0%Recovered

50%Died or euthanised

–Typical onset

How the animals did

Still unwell when reported

4 18%

Died

7 32%

Euthanised

4 18%

Not known

7 32%

Problems reported at the same time

18 82%

13 59%

11 50%

9 41%

8 36%

7 32%

5 23%

5 23%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Type: medicine.

Questions owners ask

Can Polysulfated Glycosaminoglycan cause pr-liver, lesion(s) in dogs?: 22 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Pr-liver, lesion(s) with similar medicines

Pr-liver, lesion(s) after Cefpodoxime 28 reports · 0.7% of its reports
Pr-liver, lesion(s) after Dirlotapide 21 reports · 0.7% of its reports
Pr-liver, lesion(s) after Medetomidine 23 reports · 1.1% of its reports
Pr-liver, lesion(s) after Etodolac 55 reports · 2.9% of its reports

All reported side effects of Polysulfated Glycosaminoglycan in dogs · Medicines most reported with pr-liver, lesion(s)